Market Segmentation:
- By Product Type
- Vitrectomy Machines
- Surgical Instruments
- Visualization Systems
- Disposables
- Others (Lasers, Phacoemulsification Devices, etc.)
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- Ophthalmology Clinics
- Others (Research Institutes, Military Hospitals, etc.)
- By Application
- Retinal Detachment
- Diabetic Retinopathy
- Age-related Macular Degeneration
- Macular Holes
- Epiretinal Membranes
- Vitreous Hemorrhage
- Others (Retinopathy of Prematurity, Retinal Tears, etc.)
- By Technology
- Micro-Incision Vitrectomy Surgery (MIVS)
- Transconjunctival Sutureless Vitrectomy (TSV)
- 23G Vitrectomy
- 25G Vitrectomy
- 27G Vitrectomy
- Others (Laser-Assisted Vitrectomy, Robotic-Assisted Vitrectomy, etc.)
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The Vitreoretinal Surgery Devices Market had an estimated market size worth US$ 1.85 billion in 2023.
The key factors contributing to the growth of the Vitreoretinal Surgery Devices Market include the increasing prevalence of eye disorders, technological advancements in diagnostic tools, the growing geriatric population, and the rising burden of chronic diseases.
The key factors hampering the growth of the Vitreoretinal Surgery Devices Market include the high cost of vitreoretinal surgery devices, the lack of skilled ophthalmic surgeons, reimbursement challenges in certain regions, and the risks associated with vitreoretinal surgical procedures.
The Vitrectomy Machines segment is the leading component segment in the Vitreoretinal Surgery Devices Market, driven by the increasing adoption of minimally invasive surgical techniques and the development of advanced vitrectomy systems with improved visualization and precision.
The major players operating in the Vitreoretinal Surgery Devices Market include Alcon, Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Ellex Medical Lasers Limited, IRIDEX Corporation, Meridian, Optos plc (Nikon Corporation), Reichert, Inc., and Topcon Corporation, among others.
The Vitreoretinal Surgery Devices Market is expected to grow at a CAGR of 3.5% during the forecast period, reaching a market size of US$ 2.4 billion by 2031.
The key drivers of the Vitreoretinal Surgery Devices Market include the increasing prevalence of eye disorders, technological advancements in diagnostic tools, the growing geriatric population, the rising burden of chronic diseases, and the adoption of minimally invasive surgical techniques.